It is notable that, in contrast to BNP, LAMA5 does not exhibit a significant increase in HF patients without depression, indicating that LAMA5 is not a universal biomarker for myocardial hypertrophy or HF. This evidence concerns the gene NPPB and cardiac hypertrophy.